Equities

LifeStance Health Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LFST:NSQ

LifeStance Health Group Inc

Actions
  • Price (USD)6.71
  • Today's Change-0.125 / -1.83%
  • Shares traded213.57k
  • 1 Year change-15.23%
  • Beta1.1163
Data delayed at least 15 minutes, as of Feb 09 2026 15:51 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

  • Revenue in USD (TTM)1.37bn
  • Net income in USD-9.12m
  • Incorporated2021
  • Employees8.00k
  • Location
    LifeStance Health Group Inc4800 N. Scottsdale Road, Suite 2500SCOTTSDALE 85251United StatesUSA
  • Phone+1 (602) 767-2100
  • Fax+1 (302) 636-5454
  • Websitehttps://investor.lifestance.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NeoGenomics, Inc.709.16m-113.47m1.48bn2.20k--1.76--2.08-0.8877-0.88775.556.500.470315.154.62322,346.40-7.52-4.23-8.66-4.5543.4640.72-16.00-11.713.62--0.2894--11.6510.0710.51--15.44--
Aveanna Healthcare Holdings Inc2.29bn75.46m1.64bn3.50k21.34165.4219.130.7160.36780.367811.010.04751.33--7.69654,454.604.37-10.765.72-13.0033.5731.323.29-11.05--1.830.9933--6.827.9091.88---17.60--
Surgery Partners Inc3.29bn-171.40m1.75bn15.00k--1.0110.120.5334-1.36-1.3625.9413.410.424827.715.86219,206.700.3010.97260.42971.3626.5726.230.70862.461.722.290.5007--13.5211.20-1,312.61--4.20--
Pediatrix Medical Group Inc1.92bn162.19m1.79bn2.15k10.972.019.680.93321.901.9022.6010.380.8991--7.42894,159.107.590.01089.240.0129----8.440.0155--14.610.40350.000.91642.49-64.00--2.71--
Progyny Inc1.27bn56.57m1.89bn675.0035.143.3831.011.490.62460.624613.956.501.74--4.761,879,539.007.7711.3110.9215.5422.9421.654.466.66----0.000.007.2238.42-12.41--12.83--
Select Medical Holdings Corp4.06bn-34.63m1.94bn30.00k--1.1511.870.479-0.25920.920532.7113.640.5927--4.30135,206.500.20213.000.25643.8511.9212.700.3414.19--2.250.467332.737.48-0.998210.99-15.137.17--
Addus Homecare Corporation1.35bn85.65m1.96bn6.17k22.671.8619.351.454.674.6773.4356.811.05--11.68218,426.006.655.397.586.2532.6631.716.365.43--12.660.12550.009.0612.2217.7323.315.54--
GeneDx Holdings Corp402.19m2.08m2.44bn1.00k1,361.058.3374.336.060.06190.061914.0510.120.89111.448.11402,190.000.4615-62.350.5647-78.9069.6520.780.5179-111.422.594.050.153--50.799.2670.25---18.70--
CorVel Corp941.49m105.73m2.49bn5.08k23.856.6318.192.642.042.0418.187.351.59--9.04185,515.9017.8716.1629.5226.6624.2222.6011.239.71----0.000.0012.618.6224.8014.972.02--
National Healthcare Corp1.50bn101.25m2.51bn14.96k24.932.3816.931.676.486.4896.0367.870.9574117.5911.49100,295.306.605.457.976.6138.5539.296.896.541.72--0.064646.4314.535.5852.598.360.8933.30
Lifestance Health Group Inc1.37bn-9.12m2.66bn8.00k--1.7856.681.94-0.0239-0.02393.543.840.6425--9.80133,839.30-0.4283-8.96-0.4785-9.73-----0.6667-19.11--0.56840.1589--18.5042.5569.16--8.54--
Privia Health Group Inc2.04bn18.17m2.70bn1.14k154.733.8180.451.320.14210.142115.995.771.64--4.501,791,727.001.96-3.813.68-6.2710.179.481.20-2.05----0.00--4.7417.17-37.6711.78----
Concentra Group Holdings Parent Inc2.09bn151.68m3.01bn8.76k11.547.8113.061.442.042.0420.683.010.7848--8.17238,567.905.99--6.79--28.36--7.63----3.070.7972--3.38---7.45------
Brookdale Senior Living Inc3.22bn-306.65m3.83bn24.48k----48.271.19-1.31-1.3113.82-0.02830.539--53.43131,573.60-5.13-2.05-5.72-2.2926.1422.53-9.52-4.24--0.36251.00--3.64-5.08-6.84--0.958--
Data as of Feb 09 2026. Currency figures normalised to LifeStance Health Group Inc's reporting currency: US Dollar USD

Institutional shareholders

24.87%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Sep 202532.89m8.46%
The Vanguard Group, Inc.as of 31 Dec 202516.30m4.19%
BlackRock Fund Advisorsas of 30 Sep 202511.99m3.08%
Dimensional Fund Advisors LPas of 30 Sep 20257.93m2.04%
Jennison Associates LLCas of 31 Dec 20257.39m1.90%
FIAM LLCas of 30 Sep 20256.10m1.57%
Geode Capital Management LLCas of 30 Sep 20253.96m1.02%
Barclays Bank Plc (Private Banking)as of 30 Sep 20253.51m0.90%
Brown Advisory LLCas of 30 Sep 20253.38m0.87%
SSgA Funds Management, Inc.as of 30 Sep 20253.29m0.85%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.